| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.0082 | 0.9 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.008 | 0.9 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.9 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.9 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.9 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.0077 | 0.9 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |